blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1874270

EP1874270 - PHARMACEUTICAL AEROSOL COMPOSITION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.06.2016
Database last updated on 15.06.2024
Most recent event   Tooltip17.08.2018Lapse of the patent in a contracting state
New state(s): BG		published on 19.09.2018  [2018/38]
Applicant(s)For all designated states
PARI Pharma GmbH
Moosstrasse 3
82319 Starnberg / DE
[2008/02]
Inventor(s)01 / KELLER, Manfred
Neunkirchner Strasse 60
81379 München / DE
02 / FRIEDRICH, Ingo
Auenstrasse 9
80469 München / DE
03 / JAUERNIG, Jürgen
Gustavstrasse 6
82377 Penzberg / DE
04 / LINTZ, Frank-Christophe
Steinweg 74
52222 Stolberg / DE
 [2008/02]
Representative(s)Beckmann, Claus
Kraus & Weisert
Patentanwälte PartGmbB
Thomas-Wimmer-Ring 15
80539 München / DE
[2015/33]
Former [2008/44]Beckmann, Claus
Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15
80539 München / DE
Former [2008/02]Beckmann, Claus
Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15
D-80539 München / DE
Application number, filing date06724092.906.04.2006
[2008/02]
WO2006EP03147
Priority number, dateEP2005000832215.04.2005         Original published format: EP 05008322
[2008/02]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006108556
Date:19.10.2006
Language:EN
[2006/42]
Type: A2 Application without search report 
No.:EP1874270
Date:09.01.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 19.10.2006 takes the place of the publication of the European patent application.
[2008/02]
Type: B1 Patent specification 
No.:EP1874270
Date:12.08.2015
Language:EN
[2015/33]
Search report(s)International search report - published on:EP03.05.2007
ClassificationIPC:A61K9/12, A61K38/13, A61K31/58, A61P11/00, A61P37/02, A61M15/00
[2008/02]
CPC:
A61K9/0043 (EP); A61K31/58 (EP); A61K38/13 (EP);
A61K9/007 (EP); A61M11/001 (EP); A61P11/00 (EP);
A61P37/02 (EP); A61K9/006 (EP); A61K9/10 (EP);
A61M15/0085 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/33]
Former [2008/02]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:PHARMAZEUTISCHE AEROSOL-ZUSAMMENSETZUNG[2008/02]
English:PHARMACEUTICAL AEROSOL COMPOSITION[2008/02]
French:COMPOSITION D'AÉROSOL PHARMACEUTIQUE[2008/02]
Entry into regional phase12.10.2007National basic fee paid 
12.10.2007Designation fee(s) paid 
12.10.2007Examination fee paid 
Examination procedure12.10.2007Examination requested  [2008/02]
02.03.2010Despatch of a communication from the examining division (Time limit: M06)
25.08.2010Reply to a communication from the examining division
20.06.2013Despatch of a communication from the examining division (Time limit: M04)
10.10.2013Reply to a communication from the examining division
19.03.2015Communication of intention to grant the patent
29.06.2015Fee for grant paid
29.06.2015Fee for publishing/printing paid
29.06.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.03.2010
Opposition(s)13.05.2016No opposition filed within time limit [2016/29]
Fees paidRenewal fee
29.04.2008Renewal fee patent year 03
16.04.2009Renewal fee patent year 04
17.03.2010Renewal fee patent year 05
08.04.2011Renewal fee patent year 06
27.03.2012Renewal fee patent year 07
29.04.2013Renewal fee patent year 08
26.03.2014Renewal fee patent year 09
29.04.2015Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU06.04.2006
BG12.08.2015
CY12.08.2015
CZ12.08.2015
EE12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
MC12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SI12.08.2015
SK12.08.2015
TR12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
IE06.04.2016
LU06.04.2016
[2018/38]
Former [2018/29]HU06.04.2006
CY12.08.2015
CZ12.08.2015
EE12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
MC12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SI12.08.2015
SK12.08.2015
TR12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
IE06.04.2016
LU06.04.2016
Former [2018/28]HU06.04.2006
CY12.08.2015
CZ12.08.2015
EE12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
MC12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SI12.08.2015
SK12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
IE06.04.2016
LU06.04.2016
Former [2017/38]CZ12.08.2015
EE12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SI12.08.2015
SK12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
IE06.04.2016
LU06.04.2016
Former [2017/04]CZ12.08.2015
EE12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SI12.08.2015
SK12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
LU06.04.2016
Former [2016/36]CZ12.08.2015
EE12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SI12.08.2015
SK12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/23]CZ12.08.2015
EE12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
RO12.08.2015
SE12.08.2015
SK12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/22]CZ12.08.2015
EE12.08.2015
FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
SE12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/21]FI12.08.2015
IT12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
SE12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/14]FI12.08.2015
LT12.08.2015
LV12.08.2015
NL12.08.2015
PL12.08.2015
SE12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/10]FI12.08.2015
LT12.08.2015
LV12.08.2015
PL12.08.2015
SE12.08.2015
GR13.11.2015
IS12.12.2015
PT14.12.2015
Former [2016/09]FI12.08.2015
LT12.08.2015
LV12.08.2015
GR13.11.2015
Former [2016/07]LT12.08.2015
Cited inInternational search[PX]WO2005037246  (PARI GMBH [DE], et al) [PX] 1-69 * examples 1-8 * * page 27, line 9 - page 28, line 26 * * claims 26-30 *;
 [X]US2002013271  (PARIKH INDU [US], et al) [X] 1-25,30,31,42-69 * paragraphs [0017] , [0018] * * paragraphs [0039] , [0040] * * paragraphs [0045] - [0048] * * example 1; claims 1-3 *;
 [X]US2003073676  (BIGGADIKE KEITH [GB], et al) [X] 1-25,30,31,42-69,26-29 * paragraphs [0015] , [0016] * * paragraphs [0021] , [0022] * * paragraphs [0027] , [0056] * * paragraphs [0074] - [0078] *;
 [X]WO9613254  (GLAXO WELLCOME HOUSE [GB], et al) [X] 1-25,30,31,42-69 * example 1 *;
 [X]US6086376  (MOUSSA ISKANDAR [CA], et al) [X] 1-25,30,31,42-69 * column 4, lines 24-40 * * column 5, line 54 - column 6, line 42 * * examples 1-6 *;
 [X]DE4203306  (IG SPRUEHTECHNIK GMBH [DE]) [X] 1-25,30,31,42-69,26-29 * column 1, lines 1-8 * * column 2, lines 63-68 * * column 2, lines 3-15 * * claims 1,4 * * column 2, line 68 - column 3, line 4; claims 6-9 *;
 [X]US2003055026  (BANERJEE PARTHA S [US], et al) [X] 26-29,32-41 * paragraph [0007] * * paragraphs [0010] , [0013] * * paragraphs [0057] - [0060] * * paragraphs [0072] - [0075] * * paragraphs [0094] , [0097] * * examples 1,2 * * paragraphs [0054] , [0055] *;
 [X]WO2004019985  (CIPLA LTD [IN], et al) [X] 26-29 * paragraph bridging page 2 and 3 * * page 5, third full paragraph *;
 [X]WO0178743  (GLAXO GROUP LTD [GB], et al) [X] 26-29 * examples 7,8 *;
 [X]WO0178744  (GLAXO GROUP LTD [GB], et al) [X] 26-29 * examples 7,8 *;
 [X]WO0178745  (GLAXO GROUP LTD [GB], et al) [X] 26-29 * examples 7,9 *;
 [X]US4150071  (PECINA RICHARD W) [X] 32-41 * column 2, lines 40-66; figures 1-3 *;
 [X]EP0694314  (RITZAU PARI WERK GMBH PAUL [DE]) [X] 32-41 * column 3, line 38 - column 4, line 7 * * column 5, lines 1-34 * * figures 2,5 *;
 [X]EP0729764  (MAGNI GIUSEPPINA [IT]) [X] 32-41 * column 2, lines 4-11 * * column 3, lines 2-31 * * claims 1,3,5 *;
 [X]US4125186  (MEIERHOEFER EUGENE J) [X] 32-41 * column 1, line 34 - column 2, line 17 *
by applicantDE10145361
 WO0027376
 RU2180217
 US2003073676
 DE4203306
 DE10239321
    - N. LUANGKHOT ET AL., "Characterization of salbutamol solution compared to budesonide suspensions consisting of submicron and micrometer particles in the PARI LC STAR and a new PARI Electronic Nebuliser (eFlowTM", DRUG DELIVERY TO THE LUNGS XI, 11 & 12.12.2000, pages 14 - 17
    - "Nebulizer Nanosuspensions. Important device and formulation interactions", RESP. DRUG DELIVERY VIII, (2002), pages 197 - 206
    - "Using Infant Deposition Models To Improve Inhaler System Design", RESP. DRUG DELIVERY IX, (2004), pages 221 - 231
    - WEBER ET AL., "Effect of nebuliser type and antibiotic concentration on device performance", PEDIATRIC PULMONOLOGY, (1997), vol. 23, pages 249 - 260
    - R. HUGHES ET AL., LANCET, (2003), vol. 361, no. 9375, pages 2114 - 7
    - H. STRICKER, Physikalische Pharmazie, page 440
    - S. VEMURI ET AL., "Preparation and characterization of liposomes as therapeutic delivery systems: a review", PHARM ACTA HELV., (1995), vol. 70, no. 2, pages 95 - 111
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.